Notice ID: 19d10d87346842c998ab501bdf6c9133Award NoticeAwarded
Preclinical Medications Discovery and Abuse Liability Testing
Awarded on February 22, 2022. Full description on SAM.gov.
Awarded tounder 75N95022C00004 (source: SAM.gov award notice)• $4.0M
Overview
- Posted
- March 18, 2022
- Notice type
- Award Notice
Notice details
- Place of performance
- Richmond, VA, 23284
- Last updated
- Dec 4, 2025
- Award date
- Feb 22, 2022
- Award amount (SAM.gov award notice)
- $4.0M
Identifiers
- Solicitation number
- 75N95021R00048
- Notice ID
- 19d10d87346842c998ab501bdf6c9133
- Award number (PIID)
- 75N95022C00004
Description
This contract supports the NIDA Addiction Treatment Discovery Program (ATDP), to conduct pharmacological evaluations of potential drug addiction treatment medications and to conduct preclinical abuse liability studies of new street drugs, medications, or potential medications in rodents. It also provides support for evaluation of potential pharmacotherapies for drug use disorders using rodents. The primary emphasis is on testing conducted for NIDAs ATDP. To a lesser extent, the contract will generate abuse liability data for use in decisions pertaining to scheduling of drugs under domestic laws (Controlled Substances Act) and international treaties (Single Convention and Psychotropic Convention). See Attached Award Notice for more details.
Award Overview
Award Number
75N95022C00004
Award Amount (SAM.gov award notice)
$4.0M
Award Date
Feb 22, 2022
Awardee
Awardee UEI
MLQFL4JSSAA9
Original Solicitation
Notice ID: 19d10d87346842c998ab501bdf6c9133
Posted Date: Mar 18, 2022
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- $5.8MSigned Sep 14, 2026
- $3.0MSigned Aug 10, 2026
- $3.0MSigned Jun 17, 2026
- $2.1MSigned May 8, 2026
- $2.1MSigned Jul 9, 2025
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N95021R00048- Market Research
- Pre-Solicitation
- Solicitation
- Awarded
This opportunity has been awarded.
- Market ResearchJul 7, 2021
Preclinical Medications Discovery and Abuse Liability Testing
- 2×Pre-SolicitationAug 27, 2021
Preclinical Medications Discovery and Abuse Liability Testing
- 2×SolicitationOct 22, 2021
Preclinical Medications Discovery and Abuse Liability Testing
- AwardedCurrentMar 18, 2022
Preclinical Medications Discovery and Abuse Liability Testing
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N95021R00048
Archive Date
Apr 1, 2022
Office Address
Bethesda, MD, 20892